Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
Transformation to pure-play Innovative Medicines company nears completion
The companies will leverage their respective proprietary technology platforms
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
In first-line metastatic NSCLC, KEYTRUDA-based regimens have now shown a five-year survival benefit in four trials
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
Subscribe To Our Newsletter & Stay Updated
